BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//6.6.4.4//EN TZID:America/New_York X-WR-TIMEZONE:America/New_York BEGIN:VEVENT UID:28@isnr.org DTSTART:20200612T120000Z DTEND:20200612T130000Z DTSTAMP:20200508T044515Z URL:https://isnr.org/events/webinar-developmental-trauma-neurofeedback-imp act-treatment-assessments SUMMARY:Developmental Trauma & Neurofeedback: Impact\, Treatment & Assessme nts DESCRIPTION:Instructors:  Diana Martinez MD\, PhD\, LMHC\, BCN and Ainat Rogel\, PhD\, MSW\, LICSW\, BCN\n\nIn these uncertain and crises times\, w e are all fearful and stressed. However\, we know that eventually this pan demic will be over and life will get back to normal (more or less). Sadly\ , this is not the case for a large class of people\, those suffering from developmental trauma (DT)\, for whom every day is a life of fear\, stress and one crisis after another.\n\nSo what is DT? Developmental Trauma (DT) or complex childhood trauma has arguably been one of the most important pe rsistent public health challenges in the United States with little improve ment. It has a negative impact on mental\, physiological\, and neurobiolog ical functioning\; leads to a lower quality of life and early death\; and creates a substantial financial burden for the individuals affected\, thei r families\, and the healthcare system as a whole. Moreover\, people with DT are often more resistant to traditional therapy.\n\nDT alters and dysre gulates brain activities. Neurofeedback training directly addresses these issues making it an essential treatment modality for DT. Our current resea rch on adults and children with DT has shown that neurofeedback training s ignificantly improves executive functioning and emotion regulation\, while reducing trauma symptoms. Moreover\, these neurological changes can be de tected by neuromarkers such as qEEG and ERPs.\n\nThis webinar starts with an overview of DT\, its outcome and impact\; continues with presenting our two researches about Neurofeedback and DT\; follows up with implementing them in the clinical settings\; and concludes with detecting these neurolo gical changes with qEEG and ERPs. END:VEVENT END:VCALENDAR